Our work can advance the development of new therapeutic options to help transform treatment plans for cancer patients who need them. The Biopharma team at Foundation Medicine works directly with our partners to help accelerate drug development and build strong collaborations that give millions of patients access to more personalized medicines.
With your help, we can offer access to insights and answers that can change even more lives.
Mr. Schurr brings over two decades of leadership experience in commercial oncology across the diagnostic and biotech industries. In his current role, Mr. Schurr leads the company’s collaborations with biotech and pharmaceutical partners. He is responsible for advancing Foundation Medicine’s mission by enabling its collaborators to rapidly bring novel, practice-changing therapies to patients. His team supports partners in early clinical discovery, all the way through to the global approval of companion diagnostics for therapeutics. These partnership efforts also include providing insights from the company’s extensive database of genomic information.
About the Job
The Senior Manager, Business Development-Partnership Development is responsible for developing and executing upon a comprehensive strategy in account acquisition, management and growth for FMI’s pharmaceutical and biotechnology part...
400 Summer Street, Boston, Massachusetts, United States
Biopharma
About the Job
The Director, BioPharma Brand Marketing is an integral part of the Biopharma Marketing Team within Foundation Medicine’s BioPharma commercial function. The incumbent is responsible for developing key marketing strategies, resources,...
400 Summer Street, Boston, Massachusetts, United States
Biopharma
About the Job
The Manager of Biopharma Marketing is a key member of the Biopharma Marketing team. The incumbent is a motivated and detail-oriented marketer who will assist in developing and implementing brand strategies to drive brand uptake and ...
Full Time
We can support partners from initial discovery to launch of a new therapy with our global portfolio of tests and services and our scientific and regulatory experts to fit their specific needs.
